Cargando…
Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection
Autores principales: | Kelesidis, Theodoros, Mantzoros, Christos S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313531/ https://www.ncbi.nlm.nih.gov/pubmed/35901934 http://dx.doi.org/10.1016/j.metabol.2022.155267 |
Ejemplares similares
-
Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection
por: Pinto, Melissa D., et al.
Publicado: (2022) -
Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
por: Dmytrenko, Oleksandr, et al.
Publicado: (2022) -
Hypertension as a sequela in patients of SARS-CoV-2 infection
por: Chen, Ganxiao, et al.
Publicado: (2021) -
Long-term neurological sequelae of SARS-CoV-2 infection
Publicado: (2022) -
Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)